MaxisIT Introduces DTect AI under its Portfolio of AI Agents to Transform Clinical Data Review and Quality Management
EDISON, NEW JERSEY, UNITED STATES, October 1, 2024 — MaxisIT, a leading provider of AI-driven clinical data analytics platform that accelerates clinical development launched DTect AI as part of its eXchange Data Management Workbench product. DTect AI is a revolutionary AI-powered solution for pharmaceutical and life sciences companies to optimize clinical trials data quality management. This cutting-edge platform leverages artificial intelligence to transform Integrated Data Review and Quality Management processes, ensuring unparalleled data integrity and accelerating overall data management cycle time.
DTect AI combines multiple AI models to deliver real-time anomaly detection, comprehensive data quality scoring, and intelligent recommendation systems. The product’s ability to seamlessly integrate with existing data sources across EDCs, LABs, as well as various data pipelines, while providing actionable insights sets a new industry standard for clinical data management.
The product’s AI-enabled architecture is built on a foundation of machine learning algorithms, deep learning networks, and natural language processing capabilities with conversational AI for user interactions. This advanced technology allows DTect AI to continuously learn and adapt to evolving data patterns, ensuring the highest level of accuracy in anomaly detection and quality assessment.
DTect AI represents a quantum leap in clinical trials’ data management,” said Moulik Shah, CEO of MaxisIT. “By harnessing the power of composite AI models, we’re not just improving data quality; we’re accelerating the entire drug development process. This means getting life-saving treatments to patients faster while maintaining the highest standards of data integrity.”
DTect AI is the latest addition to MaxisIT’s AI portfolio of products for clinical data and analytics, which includes solutions for end-to-end clinical development value chain and teams across clinical operations, clinical data management, medical monitoring, biostatistics & programming, commercialization. This comprehensive suite, now augmenting AI-powered tools, is designed to address critical challenges across the entire pharmaceutical value chain, from research and development to commercialization.
For more information about DTect AI and MaxisIT’s AI-driven clinical data analytics platform, join our Product Showcase at SCDM 2024 Annual Conference.
